Related Experiment Video
Updated: Oct 6, 2025

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.4K
Preserved motor memory in Parkinson's disease
Soraya Lahlou1, Ella Gabitov1, Lucy Owen2
1Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Canada.
Neuropsychologia
|January 18, 2022
Summary
Parkinson's patients retain motor memory, unaffected by dopamine medication during learning. Aging and Parkinson's disease may impact motor memory similarly, suggesting compensatory mechanisms.
Area of Science:
- Neuroscience
- Motor Control
- Cognitive Aging
Background:
- Parkinson's disease (PD) involves loss of striatal dopaminergic projections, impacting motor learning.
- The striatum is crucial for motor learning memory, but its role in PD patients is unclear.
- The influence of dopamine on motor memory consolidation at the time of learning remains unknown.
Purpose of the Study:
- To investigate motor memory in Parkinson's patients compared to controls.
- To determine if dopamine medication state affects motor memory during initial learning in PD.
- To explore post-learning consolidation and interference effects on motor memory in PD.
Main Methods:
- Assessed motor sequence memory in Parkinson's patients (On/Off medication) and age-matched controls.
- Compared motor memory performance between PD patients and older/younger control groups.
- Investigated interference effects by introducing a secondary learning task post-initial learning.
Main Results:
- Motor memory was preserved in Parkinson's patients relative to older controls.
- Dopamine medication status at initial learning did not influence motor memory.
- Parkinson's patients and older adults, unlike younger adults, showed no susceptibility to learning interference.
Conclusions:
- Motor memory appears intact in Parkinson's disease, potentially supported by non-dopamine mechanisms.
- Aging and Parkinson's disease may affect motor memory through similar pathways.
- Dopamine's role in motor memory consolidation at the time of learning is less critical than previously hypothesized.
Related Concept Videos
Parkinson's Disease: Treatment
429
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
429
Parkinson's Disease: Overview
805
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
805
Neural Regulation
40.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.5K
Role of Cerebellum and Prefrontal Cortex in Memory
634
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
634
Alzheimer's Disease: Overview
719
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
719
Alzheimer's Disease: Treatment
285
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
285

